You are here
Clinical Trials: Heart Attack
Each Clinical Trial will open in a new browser window or tab.
Condition: Coronary Artery Disease
Interventions: Drug: Intensive statin; Drug: Routine statin
Sponsors: Ji Huang; National Natural Science Foundation of China
Not yet recruiting - verified July 2012
Interventions: Drug: Intensive statin; Drug: Routine statin
Sponsors: Ji Huang; National Natural Science Foundation of China
Not yet recruiting - verified July 2012
Conditions: Myocardial Infarction; Death
Intervention: Procedure: Bone Marrow aspiration and intracoronary reinfusion
Sponsor: Queen Mary University of London
Recruiting - verified June 2015
Intervention: Procedure: Bone Marrow aspiration and intracoronary reinfusion
Sponsor: Queen Mary University of London
Recruiting - verified June 2015
Condition: Myocardial Infarction
Intervention: Biological: CAP-1002 Allogeneic Cardiosphere-Derived Cells
Sponsors: Capricor Inc.; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI); California Institute for Regenerative Medicine (CIRM)
Recruiting - verified March 2016
Intervention: Biological: CAP-1002 Allogeneic Cardiosphere-Derived Cells
Sponsors: Capricor Inc.; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI); California Institute for Regenerative Medicine (CIRM)
Recruiting - verified March 2016
Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients.
Condition: Acute Myocardial Infarction
Interventions: Other: Autologous Bone marrow mononuclear cells; Other: Placebo control
Sponsors: TotipotentRX Cell Therapy Pvt. Ltd.; TotipotentRX Corporation
Not yet recruiting - verified September 2013
Interventions: Other: Autologous Bone marrow mononuclear cells; Other: Placebo control
Sponsors: TotipotentRX Cell Therapy Pvt. Ltd.; TotipotentRX Corporation
Not yet recruiting - verified September 2013
Conditions: Acute Myocardial Infarction; Heart Failure
Intervention: Procedure: PCI and Stem Cells or Placebo injections
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified September 2015
Intervention: Procedure: PCI and Stem Cells or Placebo injections
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified September 2015
Conditions: Old Myocardial Infarction; Chronic Myocardial Ischemia; Left Ventricular Dysfunction
Interventions: Procedure: bone marrow mononuclear cells injection; Procedure: placebo intramyocardial injection
Sponsor: Chinese PLA General Hospital
Recruiting - verified December 2010
Interventions: Procedure: bone marrow mononuclear cells injection; Procedure: placebo intramyocardial injection
Sponsor: Chinese PLA General Hospital
Recruiting - verified December 2010
Condition: Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)
Intervention: Procedure: Hypoxia-stressed BMSCs transplantation to cure MI
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting - verified November 2010
Intervention: Procedure: Hypoxia-stressed BMSCs transplantation to cure MI
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting - verified November 2010
Conditions: Myocardial Infarct; Heart Failure
Intervention: Procedure: Injection of stem cells at time of coronary artery bypass grafting
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Miltenyi Biotec, Inc.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Maisonneuve-Rosemont Hospital
Recruiting - verified March 2014
Intervention: Procedure: Injection of stem cells at time of coronary artery bypass grafting
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Miltenyi Biotec, Inc.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal; Maisonneuve-Rosemont Hospital
Recruiting - verified March 2014
Condition: Anterior Wall Myocardial Infarction
Interventions: Biological: Plasma-Lyte A and 25% Autologous Plasma; Biological: Autologous EPCs; Biological: Autologous EPCs Transfected with human eNOS
Sponsors: Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2016
Interventions: Biological: Plasma-Lyte A and 25% Autologous Plasma; Biological: Autologous EPCs; Biological: Autologous EPCs Transfected with human eNOS
Sponsors: Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2016
Condition: Acute Myocardial Infarction
Intervention: Genetic: Stem Cell Transplantation
Sponsors: National Heart Institute, Mexico; National Center of Blood Transfusion Mexico.
Recruiting - verified July 2008
Intervention: Genetic: Stem Cell Transplantation
Sponsors: National Heart Institute, Mexico; National Center of Blood Transfusion Mexico.
Recruiting - verified July 2008
2023 AlphaMed Press ©